Current Clinical Trials
LSO has completed Aptocine treatment in a Phase 3 trial in hepatocellular carcinoma and in a Phase 3 trial in colorectal cancer metastatic to the liver. LSO has also completed treatment in Phase 1 and Phase 2 clinical trials in benign prostatic hyperplasia (BPH).
| Indication | Preclinical | Phase 1 | Phase 2 | Phase 3 |
|---|---|---|---|---|
| Hepatocellular Carcinoma | ||||
| Metastatic Colorectal Cancer | ||||
| Benign Prostatic Hyperplasia |